Pesquisa

Edição
Título
Autores
CXCR4 chemokine receptor expression in tumor tissue as an additional predictor factor for patients with colon cancer
Orlova R., Ivanova A., Raskin G., Kutukova S., Androsova A., Erdniev S., Zhukova N., Belyak N., Popova N., Avramenko I., Antimonik N., Zorina E.
Predictive and prognostic significance of stemness gene amplifications in the breast tumor in patients who received neoadjuvant chemotherapy
Kazantseva P., Slonimskaya E., Tsyganov M., Ibragimova M., Doroshenko A., Tarabanovskaya N., Litviakov N.
Ways to improve efficiency of endocrino-therapy of breast cancer: new targeted cells, new therapeutic opportunities
Semiglazov V., Semiglazov V., Nikolaev K., Dashyan G., Komyakhov A., Paltuev R., Appolonova V., Donskikh R., Tseluyko A., Semiglazova T., Zhiltsova E., Krivorotko P.
SYSTEMIC THERAPY FOR ADVANCED OVARIAN CANCER IN BRCA1 MUTATION CARRIERS -NEW THERAPEUTIC APPROACHES: RESULTS OF A PROSPECTIVE NON-RANDOMIZED MULTI-CENTER STUDY
Gorodnova T., Sokolenko A., Ivantsov A., Kotiv K., Yakovleva M., Mikheeva O., Mikhaylyuk G., Lisyanskaya A., Guseinov K., Nekrasova E., Smirnova O., Sidoruk A., Bondarev N., Matveeva N., Meshkova I., Mikaya N., Petrik S., Manikhas G., Protsenko S., Berlev I., Belyaev A., Imyanitov E.
Prognostic value of the dynamics of disseminated tumor cells in the bone marrow in patients with disseminated adenocarcinoma of the stomach or the esophagogastric junction
Besova N., Obarevich E., Beznos O., Tupitsyn N., Davydov M.
De-escalation and escalation of treatment of patients with HER2-positive breast cancer
Semiglazov V., Semiglazov V., Nikolaev K., Komyakhov A., Semiglazova T., Paltoev R., Donskikh R., Tseluyko A., Artemyeva A., Bashlyk V., Miryusupova G., Dashyan G.
Optimal tactics of adjuvant treatment of patients with endometrial cancer
Khokhlova S., Bazaeva I.
RADICAL RETROPUBIC AND ROBOT-ASSISTED PROSTATECTOMY IN PATIENTS WITH LOCALIZED PROSTATE CANCER: A COMPARATIVE ANALYSIS OF ONCOLOGICAL AND FUNCTIONAL OUTCOMES
Rasner P., Kolonarev K., Govorov A., Kotenko D., Pushkar D.
RESOLUTION SUMMARIZING THE RESULTS OF THE EXPERT COUNCIL "MODERN APPROACHES TO THE TREATMENT OF HER2-NEGATIVE METASTATIC BREAST CANCER. PROSPECTS FOR THE USE OF ERIBULIN AS A PART OF COMBINATION THERAPY FOR BREAST CANCER"
Artamonova E., Bolotina L., Gligorov Z., Zhukov N., Zhukova L., Imyanitov E., Karabina E., Kovalenko E., Lichinitser M., Manzyuk L., Semiglazov V., Semiglazova T., Stroyakovsky D.
EFFECT OF SPECIAL TREATMENT ON THE DEVELOPMENT OF OSTEOPOROSIS IN PATIENTS WITH BREAST CANCER IN PREMENOPAUSAL PERIOD
Tretyakova N.
Klinicheskiy sluchay uspeshnogo lecheniya HER-pozitivnogo disseminirovannogo raka zheludka s polnym i prodolzhitel'nym effektom
Vakhabova Y., Filimonyuk A., Lodygina K., Vorontsova K., Lichinitser M.
Kadsila (trastuzumab emtanzin, T-DM1): pervyy kon\"yugat antitela i khimiopreparata v lechenii HER2-polozhitel'nogo raka molochnoy zhelezy
Borisova E., Gutorov S., Lichinitser M.
Opyt primeneniya oktreotida v prolongirovannoy forme vypuska pri lechenii kastrat-rezistentnogo raka predstatel'noy zhelezy
Mishugin S., Mordovin A., Gritskevich A., Rusakov I.
Eribulin v lechenii metastaticheskogo raka molochnoy zhelezy s troynym negativnym fenotipom
Zhukova L., Okruzhnova M., Chasovnikova E.
ROL' LIPOSAKTsII V LEChENII POSTMASTEKTOMIChESKOY LIMFEDEMY
Zabelin M., Sidorov D., Safonov A.
Rak molochnoy zhelezy i beremennost'
Dashyan G., Semiglazov V., Topuzov E., Ivanov V., Vorotnikov V., Lalak I., Bryantseva Z., Usungvan M., Tseluyko A.
PRIMENENIE BISFOSFONATOV DLYa PROFILAKTIKI RAZVITIYa KOSTNYKh METASTAZOV U BOL'NYKh RAKOM MOLOChNOY ZhELEZY
Semenov N.
Adjuvant hormonal therapy in perimenopausal women with ER-positive breast cancer
Semiglazov V., Semiglazov V.
Place of drug therapy in the prevention and treatment of bone complications of prostate cancer
Rusakov I., Kosov A., Mishugin S.
URINARY INCONTINENCE IN MEN
Markosyan T., Korchazhkina N., Nikitin S., Markosyan T., Korchazhkina N., Nikitin S.
SEARCH FOR MARKERS OF EFFICIENCY OF BEVACIZUMAB IN METASTATIC COLORECTAL CANCER
Gutorov S., Borisova E., Chichikov E., Denisenko A., Borisova Y., Chichikov Y., Denisenko A., Gutorov S.
IMAGING OF INDIVIDUAL LYMPH OUTFLOW TRACTS FOR DETERMINATION OF TOPOGRAPHY OF RADIATION FIELD IN BREAST CANCER PATIENTS
Kanaev S., Novikov S., Krivorot'ko P., Semiglazov V., Zhukova L., Zotova O., Kanaev S., Novikov S.
PHASE II STUDY OF COMBINATION OF PEMETREXED (ALIMTA®) AND CISPLATIN AS FIRST-LINE TREATMENT OF STAGE IV STOMACH CANCER OR RECURRENT GASTRIC CANCER
Hailenko V., Mihailov S., Hasanov R., Lybennikov D., Gotovkin E., Helen Yin -., Sholohov E., Khaylenko V.
ADJUVANT ANTI-HER2 THERAPY FOR BREAST CANCER
Semiglazov V., Semiglazov V., Ivanov V., Bessonov A., Shchedrin D., Zhiltsova Y., Dashyan G., Paltuev R., Semiglazova T., Penkov K., Vasilyev A., Semiglazov V., Semiglazov V., Ivanov V., Bessonov A., Shchedrin D., Zhil'tsova E., Dashyan G., Paltuev R., Semiglazova T., Pen'kov K., Vasil'ev A.
Cardiotoxicity and chronic heart failure in the treatment of patients with gastric cancer: pathogenesis, methods of prevention and therapy
Astakhova Z., Zaseeva M.
Conversion therapy for disseminated gastric cancer. Interim results of a retrospective analysis of our own data
Besova N., Obarevich E., Tryakin A., Gavrilova D., Nered S., Kalinin A., Stilidi I.
Combination of sarcoidosis and sigmoid colon cancer: a clinical observation
Dmitrieva N., Mavlyavieva E., Chernikova Y., Fedotov E., Mirilashvili T.
Evaluation of immune response checkpoint dynamics in patients with lung cancer receiving immune therapy
Mochalova A.
Predictive and prognostic role of tumor-infiltrating lymphocytes (TILs) in early triple-negative breast cancer
Abdulaeva S., Semiglazova T., Artemyeva A., Kudaibergenova A., Sharashenidze S., Tseluyko A., Paltuev R., Semiglazov V., Krivorotko P., Semiglazov V.
Dual HER2 blockade with pertuzumab+trastuzumab on the eve of a new era in the treatment of HER2-positive breast cancer
Zhukova L., Artamonova E., Ganshina I., Kolyadina I., Vorontsova K., Sekhina O., Grechukhina K.
Impact of nutritional deficiency and sarcopenia on the efficacy of neoadjuvant chemotherapy in patients with locally advanced gastric cancer: a retrospective study
Brish N., Semiglazova T., Karachun A., Tkachenko E., Artemieva A., Shevkunov L., Ulyanchenko Y., Golovanova T., Alekseeva Y., Sharashenidze S., Strakh L., Filatova L., Semiglazov V., Kasparov B., Protsenko S., Belyaev A.
Prevention of colorectal cancer in patients with inflammatory bowel disease
Bikbavova G., Livzan M., Fedorin M.
Endocrine resistance in breast cancer treatment
Dzhelyalova M., Semiglazov V.
A clinical case of using ribociclib with an aromatase inhibitor in metastatic hormone-receptor-positive HER2-negative breast cancer with a rare location of metastasis
Fateeva A., Zyuzyukina A., Zukov R.
Assessment of intensified neoadjuvant chemotherapy regimens for locally advanced cervical cancer
Smirnova O., Bondarev N., Ulrikh E., Mikaya N., Kotiv K., Petrova A., Ivantsov A., Gorodnova T., Nekrasova E., Lavrinovich O., Yakovleva M., Abramova A., Malyutina D., Parsyan S., Mkrtchyan G., Ibragimov Z., Trifanov Y., Sidoruk A., Urmancheeva A., Berlev I.
The use of ramukirumab in the treatment of metastatic gastric cancer in real clinical practice
Belyak N., Kutukova S., Orlova R., Zhukova N., Erdniev S., Zorina E., Avramenko I., Antimonik N., Popova N., Ivanova A., Androsova A.
Potentials of drug therapy for metastatic/recurrent cervical cancer
Ulrikh E., Semiglazova T., Khalimbekova D., Smirnova O., Ulrikh D., Urmancheeva A.
CYCLIN-DEPENDENT KINASE INHIBITORS - NEW THERAPEUTIC OPTION FOR PATIENTS WITH HORMONE-DEPENDENT HER2-NEGATIVE BREAST CANCER: CLINICAL EXPERIENCE
Sakaev D., Iskhakova A., Kunafina R.
Modern approaches to the diagnosis and treatment of acute pyelonephritis in patients with bladder cancer
Kaprin A., Kostin A., Vorobyev N., Popov S.
GASTRIC MICROBIOTA AND POTENTIALS OF PROBIOTICS IN THE ERADICATION OF H. PYLORI
Kornienko E., Parolova N.
Chemotherapy of endometrial cancer -E.V. Bakhidze, A.V. Belyaeva 29 Optimal tactics of adjuvant treatment of patients with endometrial cancer
Khokhlova S., Bazaeva I.
CLINICAL OBSERVATION OF RARE METASTASIS OF GASTRIC ADENOCARCINOMA TO THE PENIS
Trusilova E., Ivanov A., Besova N., Skvortsov I., Tsymzhitova N.
LONG-TERM RESULTS OF SECOND LINE ANTICANCER THERAPY OF METASTATIC COLORECTAL CANCER AND THEIR RELATIONSHIP WITH CLINICAL AND MORPHOLOGICAL CHARACTERISTICS
Vorontsova K., Chemoglazova E., Rotobelskaya L., Vyshinskaya G.
ALK-pozitivnyy nemelkokletochnyy rak legkogo i metody ego lecheniya: obzor literatury
Laktionov K., Reutova E., Sarantseva K.
NOVYY MEZhDUNARODNYY (KIOTSKIY) KONSENSUS PO VEDENIYu PATsIENTOV S GASTRITOM
Tsukanov V., Kasparov E., Vasyutin A., Onuchina E., Tonkikh Y.
Kompleksnoe lechenie bol'nykh s tserebral'nymi metastazami kolorektal'nogo raka
Karakhan V., Naskhletashvili D., Mitrofanov A.
EVEROLIMUS (AFINITOR): NOVYE VOZMOZhNOSTI TERAPII ZLOKAChESTVENNYKh OPUKhOLEY
Gorbunova V.
Osobennosti predoperatsionnoy podgotovki i vedeniya bol'nykh kolorektal'nym rakom starcheskogo vozrasta
Markar'yan D., Tsar'kov P., Minnibaeva E.
GORMONAL'NAYa TERAPIYa RAKA PREDSTATEL'NOY ZhELEZY
Chernyaev V.
Adjuvant therapy with trastuzumab for early-stage breast cancer: 12 or 24 months (based on ESMO data, Vienna, october, 2012)
Zhukova L., Lichinitser M.
PREVALENCE AND PRINCIPLES OF TREATMENT OF BARRETT'S ESOPHAGUS
Maev I., Tsukanov V., Butorin N., Kasparov E., Bichurina T., Vasyutin A., Maev I., Tcukanov V., Butorin N., Kasparov E., Bichurina T., Vasyutin A.
MALIGNANT TUMORS OF URINARY BLADDER
Pavlov V., Izmaylov A., Izmaylova S., Mustafin A., Galimzyanov V., Urmantsev M., Pavlov V., Ismaylov A., Ismaylova S., Mustafin A., Galimzyanov V., Urmancev M.
BONE METABOLISM AND EFFECTIVENESS OF ZOLEDRONIC ACID IN LOCALLY ADVANCED AND DISSEMINATED PROSTATE CANCER
Glybochko P., Alyaev Y., Vinarov A., Demidko Y., Zelenova O., Shpot' E., Glybochko P., Alyaev Y., Vinarov A., Demidko Y., Zelenova O., Shpot Y.
RESORBA IN THE TREATMENT OF BONE METASTASIS OF BREAST CANCER
Vladimirova L., Abramova N., E Storozhakova A., Paly A., Vladimirova L., Abramova N., Storozhakova A., Paliy A.
NEOADJUVANT THERAPY OF THE BREAST CANCER WITH HIGH EXPRESSION OF HER-2
Semiglazov V., Manikhas A., Bozhok A., Dashjan G., Vasilev A., Petrovsky S., Matsko D., Semiglazov V., Paltuev R., Ivanov V., Zernov K., Donskikh R., Bessonov A., Shamina Y., Semiglazov V., Manikhas A., Bozhok A., Vasil'ev A., Petrovskiy S., Matsko D., Semiglazov V., Dashyan G., Paltuev R., Ivanov V., Zernov K., Donskikh R., Bessonov A., Shamina E.
Case report: long-term response to osimertinib in metastatic non-small cell lung cancer with a rare mutation in EGFR gene exon 20
Nelyubina L., Reutova E., Laktionov K., Stroganova A.
Adherence to adjuvant hormonal therapy for luminal HER2-negative breast cancer: results of a patient survey
Gordeeva O., Bokova S.
Data in the treatment of colon cancer from real clinical practice in Tashkent, Uzbekistan
Khakimova G., Tryakin A.
Possibilities of overcoming hormone resistance in patients with metastatic HR+ HER2- breast cancer using the drug alpelisib in various subgroups in real clinical practice
Orlova R., Gluzman M., Vakhitova A.
Analysis of the effectiveness of various neoadjuvant chemotherapy regimens in patients with T1-3N1-3M0 I–IIIC stage locally advanced breast cancer
Pesotsky R., Semiglazov V., Krivorotko P., Tabagua T., Zernov K., Emelyanov A., Yerechshenko S., Amirov N., Mortada V., Ulrikh D., Levchenko V., Rychagov K., Zirov K., Evseev V.
Clinical significance of genetic polymorphism of tamoxifen metabolic enzymes and transporters in breast cancer: results of a population-based cohort study
Golubenko E., Savelyeva M., Sozaeva Z., Poddubnaya I., Korennaya V.
Clinical immunology of breast cancer
Tseluiko A., Semiglazov V., Kudaibergenova A., Artemyeva A., Paltuev R., Donskikh R., Pesotsky R., Krivorotko P.
Neoadjuvant immunotherapy for non-small cell lung cancer
Semenova A., Protsenko S., Teletaeva G., Latipova D., Novik A.
Optimization of the tactics of adjuvant chemotherapy in patients with colon cancer taking into account clinical and morphological characteristics
Ivanova A., Orlova R., Raskin G., Kutukova S.
Rare case of pheochromocytoma with calcitonin hypersecretion
Rebrova D., Rusakov V., Fedorov E., Krasnov L., Vorokhobina N., Shikhmagomedov S., Vorobyev S., Sleptsov I., Chernikov R., Savelyeva T., Semenov A., Chinchuk I., Sablin I., Pridvizhkina T., Fedotov Y.
Optimal treatment strategy for a patient with advanced ovarian cancer without deterioration in the quality of life: a clinical case
Khokhlova S.
Influence of FOLFIRINOX on the achievement of resistability in patients with rectal and liver metastases
Khakimov G., Dzhumaniezov K., Kadyrov S., Khakimova G., Abdulkhuseynova S., Poluzhkina I.
Intermediate assessment of the results of a clinical study of a neoadjuvant combined treatment of patients with high-risk and very high-risk prostate cancer
Buevich N., Protsenko S., Nosov A., Reva S., Artemyeva A., Berkut M.
Current aspects of the treatment of BRCA-associated ovarian cancer
Rumyantsev A.
INTERCELLULAR ADHESION MOLECULES (E-CADHERIN, ß-CATENIN) IN COLORECTAL CANCER: CHARACTERISTICS; ROLE IN MECHANISMS OF TUMOR INVASION, METASTASIS AND REGULATION OF TUMOR PROGRESSION; INFLUENCE ON PROGNOSIS (LITERATURE REVIEW)
Darenskay A., Dobrova N., Stepanova E.
Skin melanoma in practice of dermatologist
Sergeev Y., Mordovtseva V., Sergeev V.
Ixempra - new possibilities of cytostatic therapy of breast cancer
Lubennikova E., Zhukova L., Arutyunyan E.
Cashuistic case of treatment of discemned small-cell lung cancer
Khakimova G., Titova T., Kuzminov A., Gorbunova V., Delektorskaya V., Borisova T.
METASTATIC GASTRIC CANCER: DESCRIPTION OF CLINICAL CASE
Abramov M., Bardovskaya K., Mescheryakov A., Medvedeva B.
FIRST-LINE ENDOCRINE THERAPY OF HORMONE RECEPTOR-POSITIVE HER2-NEGATIVE METASTATIC BREAST CANCER. TIME OF CHANGE AFTER A LONG-TERM CALM PERIOD
Zhukova L., Manikhas A.
TARGETED THERAPY IN COMPLEX TREATMENT OF RENAL CANCER PATIENTS WITH BRAIN METASTASES
Naskhletashvili D.
Sovremennye vozmozhnosti lecheniya bol'nykh disseminirovannym kolorektal'nym rakom: II liniya lekarstvennoy terapii -
Vorontsova K., Dobrova N., Vyshinskaya G.
Issledovanie faktorov rosta pri razlichnykh zabolevaniyakh predstatel'noy zhelezy
Kostin A., Andryukhin M., Pul'bere S., Motin P., Agaev N.
Opyt lecheniya bol'nykh metastazami kolorektal'nogo raka: irinotekan+raltitreksed (2-ya liniya khimioterapii)
Vorontsova K., Dobrova N., Vakhabova Y., Vyshinskaya G.
ALK-POZITIVNYY NEMELKOKLETOChNYY RAK LEGKOGO: NOVYE PATsIENTY I NOVYE VOZMOZhNOSTI LEKARSTVENNOGO LEChENIYa
Breder V., Laktionov K.
Gormonoterapiya metatstaticheskogo i retsidivnogo raka endometriya
Bakhidze E.
NOVYE VOZMOZhNOSTI TERAPII BOL'NYKh METASTATIChESKIM RAKOM MOLOChNOY ZhELEZY, POLUChAVShIKh RANEE ANTRATsIKLINI TAKSAN-SODERZhAShchUYu KhIMIOTERAPIYu: OBZOR LITERATURY I KLINIChESKIY SLUChAY
Zhukova L.
Hormonal treatment of breast cancer: optimal sequence and issues of overcoming the resistance
Borisova E., Gutorov S., Vorontsov A.
Current potentials for the drug therapy of adrenocortical cancer
Filimonyuk A.
VEDENIE PATsIENTOV S KhRONIChESKIMI VIRUSNYMI GEPATITAMI I ONKOLOGIChESKOY PATOLOGIEY
Bogomolov P., Bueverov A., Matsievich M., Voronkova N., Kokina K., Koblov S., Trofimova M.
CLINICAL EXPERIENCE OF USE OF BEVACIZUMAB (AVASTIN) IN PATIENTS WITH METASTATIC BREAST CANCER WITH UNIDENTIFIED HER2/NEW AND ER PR-RECEPTOR STATUS
Konstantinova M., Shikina V., Makshantsev A., Konstantinova M., Shikina V., Makshantsev A.
DRUG ZOMETA IN ADDITION TO THE CHEMOTHERAPY SIGNIFICANTLY INCREASES OVERALL SURVIVAL IN PREVIOUSLY UNTREATED PATIENTS WITH MULTIPLE MYELOMA
Zhukov N., Zhukov N.
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF CRYPTORCHIDISM UNDER PRESENT-DAY CONDITIONS
Hamidov S., Ovchinnikov R., Myasnikov D., Pavlovichev A., Tazhetdinov O., Tkhagapsoeva R., Gamidov S., Ovchinnikov R., Myasnikov D., Pavlovichev A., Tazhetdinov O., Tkhagapsoeva R.
201 - 288 de 288 resultados << < 1 2 3 
Dicas:
  • Palavras-chave são sensíveis a maiúsculas
  • Preposições e conjunções ingleses são ignoradas
  • Busca é feita por todos os palavras-chave (agente AND experimentador) por omissão
  • Use OR para pesquisar um termo exato, ex.: educação OR formação
  • Use parênteses para criar frases complexas, ex.: arquivo de ((revistas OR conferências) NOT teses)
  • Para pesquisar uma frase precisa use aspas duplas, ex.: "investigações científicas"
  • Exclua uma palavra utilizando o sinal - (hífen) ou operador NOT; ex.: concurso-de beleza ou concurso NOT de beleza
  • Use * como caractere-coringa, ex.: científic* recuperará as palavras "científico", "científicos", etc.